−2.58 MUSD
28.83 MUSD
7.53 M
About Exicure, Inc.
Sector
Industry
CEO
Paul Kang
Website
Headquarters
Chicago
Employees (FY)
13
Founded
2011
ISIN
US30205M2008
FIGI
BBG00GTJCSB4
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
$XCUR Next Target PTs .45-1.20-1.90 and higherExicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clini
Exicure (NASDAQ: $XCUR) Could Double Or More In Near-Term! 🎯Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clini
$XCUR Exicure Inc On Breakout watchlist
200ma break pre-market
downtrend is major resistance.
RSI & Momentum Bullish
targets as per chart
XCUR: Got Ways to Go $3.30 TargetFirst off, please don't take anything I been saying seriously or as financial advice. As always, this is on an opinion based basis. That being said XCUR has a reasonable target of reaching $3.30 soon in my opinion. It is still on a positive retracement wave looking at the entire chart history, and t
Exicure, Inc uptrend targets Exicure, Inc. is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). It focuses on neurology, immuno-oncology, inflammatory diseases, and other genetic disorders. The company was founded by
Exicure Inc. P-Modeling Pt Z. The Cajun Ship of ObliterationWelcome Hyperspace Archaeologists,
Come for the laughs, stay for the Art.
___________________
Find the "we are here" bubble.
I am most likely wrong...
Meh . Who cares.
but what... if..
good enough for me! All in. #pewpeww
__________________________________
Trade Taken:
Entry Range is $2.38 - $2.4
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XCUR is 0.60 USD — it has decreased by 5.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Exicure, Inc. stocks are traded under the ticker XCUR.
Exicure, Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
XCUR earnings for the last quarter are −1.04 USD whereas the estimation was −0.90 USD which accounts for −15.56% surprise. Estimated earnings for the next quarter are −0.19 USD. See more details about Exicure, Inc. earnings.
Exicure, Inc. revenue for the last quarter amounts to 2.02 M USD despite the estimated figure of 3.90 M USD. In the next quarter revenue is expected to reach 3.90 M USD.
Yes, you can track Exicure, Inc. financials in yearly and quarterly reports right on TradingView.
XCUR stock has fallen by 2.05% compared to the previous week, the month change is a 5.31% fall, over the last year Exicure, Inc. has showed a 40.25% decrease.
Like other stocks, XCUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Exicure, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 13.00 employees. See our rating of the largest employees — is Exicure, Inc. on this list?